Clostridium difficile infection
GPTKB entity
Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Clostridium_difficile
|
| gptkbp:associated_with |
Hospitalization
Healthcare settings Increased healthcare costs Long-term care facilities Increased mortality risk Increased length of hospital stay |
| gptkbp:caused_by |
gptkb:Clostridium_difficile
|
| gptkbp:complications |
Dehydration
Toxic megacolon Colorectal perforation |
| gptkbp:healthcare |
gptkb:battle
|
| https://www.w3.org/2000/01/rdf-schema#label |
Clostridium difficile infection
|
| gptkbp:is_characterized_by |
Antibiotic-associated diarrhea
Pseudomembranous colitis |
| gptkbp:is_often_used_in |
gptkb:Africa
gptkb:Europe gptkb:Asia gptkb:Australia gptkb:North_America |
| gptkbp:is_popular_in |
Varies by region
Higher in hospitalized patients Higher in older adults |
| gptkbp:is_protected_by |
Hand hygiene
Use of personal protective equipment Antibiotic stewardship Environmental cleaning Isolation of infected patients |
| gptkbp:is_recognized_by |
gptkb:1935
|
| gptkbp:risk_factor |
Age over 65
Antibiotic use |
| gptkbp:social_responsibility |
Stool test
PCR test Recurrent infections Associated with antibiotic misuse Common in hospitals Common in nursing homes Enzyme immunoassay Hypervirulent strains Increasing incidence |
| gptkbp:symptoms |
gptkb:Fever
Diarrhea Abdominal pain |
| gptkbp:transmission |
Fecal-oral route
|
| gptkbp:treatment |
Antibiotics
Metronidazole Vancomycin Bezlotoxumab Fecal microbiota transplantation Probiotics (under investigation) |